Warrants |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants |
11. Warrants The following is a continuity schedule of the Company’s common share purchase warrants:
During the year ended March 31, 2023 and 2022, 79,683 and 42,684 warrants, respectively, expired in accordance with their terms. During the year ended March 31, 2023 the Company granted 400,000 warrants at $0.40 per share with an expiration date of March 23, 2028. The following is a summary of common share purchase warrants outstanding as of March 31, 2023.
The weighted-average remaining contractual term of the outstanding warrants was 5 years. |
X | ||||||||||
- Definition The entire disclosure for purchase of Warrants during the period. No definition available.
|
X | ||||||||||
- References No definition available.
|